Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: Description of a clinical case and literature review

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 4, 2009, Pages 314-316

  Pellicelli, Adriano M ^a   D'Ambrosio, Cecilia ^a   Villani, Roberto ^a   Cerasari, Giuseppe ^a   Ialongo, Pasquale ^a   Cortese, Andrea ^a   Grillo, Lucia Rosalba ^a   Soccorsi, Fabrizio ^a  

^a NONE

Author keywords

Immunocompromised patients; Liver cirrhosis; Mucor; Rhino orbital mucormycosis; Surgical treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAXILLOFACIAL DISORDER; MUCORMYCOSIS; NEPHROTOXICITY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; IMMUNOCOMPETENCE; LIVER CIRRHOSIS; MIDDLE AGED; MUCORMYCOSIS; ORBIT EVISCERATION; ORBITAL DISEASES; PARANASAL SINUS DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949833426     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000400015     Document Type: Article

References (14)

1. Roden M.M, Zaoutis T.E, Buchanan W.L., Knudsen TA, Sarkisova TA, Schaufele RL et al. Epidemiology and outcome fo zygomycosis: a review of 929 reported cases: Clin Infect Dis. 2005;41: 634-653.
2. El Serag H.B, Anand B., Richardson P., Rabeneck L. Association between hepatitis C infection and other infectious disease: a case for targeted screening?. Am J Gastroenterol. 2003; 98: 167-174.
3. Abbas Z., Jafri W., Rasool S., Abid S, Hameed I. Mucormycosis in patients with complicated cirrhosis. Singapore Med J. 2007; 48:69-73.
4. Hofman P., Gari-Toussaint M., De Bievre C., Michiels JF, d'Horpock FA, Loubière R. Rhino-orbito-cerebral mucormycosis caused by Rhizopus oryzae. A typical case in a cirrhotic patients: Ann Pathol 1993; 13:180-183
5. Georgopoulou S., Kounougeri E, Katsenos C, Rizos M, Michalopoulos A. Rhinocerebral mucormycosis in a patient with cirrhosis and chronic renal failure. Hepatogastroenterology. 2003; 50:843-845.
6. Kikuchi H., Kinoshita Y:, Arima K, Doh-ura K, Hisatomi Y, Hashimoto T, Sakai H, Nawata H, Iwaki T. An autopsy case of rhino-orbito-cerebral mucormycosis associated with multiple cranial nerve palsy and subsequent subarachnoid hemorrhage. Rinsko Shinkeigaku. 1998; 38:252-255
7. Zein NN., Abdulkarim AS., Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end stage liver cirrhosis due to hepatitis C, alcohol or cholestatic disease. J.Hepatol 2000; 32:209-217
8. Fiuza C., Salcedo M., Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis. 2000;182:526-533
9. Campbell A.C., Dronfield M.W, Toghill P.J, Reeves WG. Neutrophil function in chronic liver disease. Clin Exp.Immunol. 1981; 45:81-89.
10. Kusaba N, Kumashiro R., Ogata H, Sata M, Tanikawa K. In vitro study of neutrophil apoptosis in liver cirrhosis. Intern. Med.1998;37:11- 17
11. Kameh DS, Gonzalez OR, Pearl GS, Walsh AF, Gambon T, Kropp TM. Fatal rhino-orbital-cerebral zygomycosis. South Med J. 1997; 90:1133-5
12. Millwala F., Nguyen GC., Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non hepatic surgery: risk assessment and managment. World J Gastroenterol. 2007; 14:4056-4063
13. Walsh T., Hiemenz J.W., Seibel N, Perfect JR, Horwith G, Lee L, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998;26:1383-1396
14. Ng T.T.C, Dennings D.W. Liposomal amphotericin B (Ambisome) therapy in invasive fungal infections. Arch Intern Med. 1995;155: 1093-1098.